학술논문

Recall radiation myelitis after stereotactic radiation and dabrafenib in metastatic melanoma.
Document Type
Article
Source
Acta Oncologica. Jan2017, Vol. 56 Issue 1, p109-110. 2p.
Subject
*ANTINEOPLASTIC agents
*CANCER chemotherapy
*COMBINED modality therapy
*MELANOMA
*METASTASIS
*MYELITIS
*TREATMENT effectiveness
*ADVERSE health care events
*PHARMACODYNAMICS
Language
ISSN
0284-186X
Abstract
A letter to the editor is presented that is based on the subject of metastaticmelanoma which is treated with the method of using stereotactic radiation, radiation myelitis and dabrafenib. It also includes a case study of a 48-year-old white woman who is diagnosed with the disease of metastatic melanoma and is treated with the medications incluidng nivolumab, ipilimumab, and stereotactic radiotherapy.